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A B S T R A C T
Cigarette smoking is an important risk factor for all respiratory tract diseases. Unfortunately, the symptoms develop
slowly, thus patients feel the consequences of the slowly developing inflammation too late. The inflammation first devel-
ops in the area of respiratory bronchioles. In this stage, the disease is asymptomatic. The study included a sample of 31
smokers, mean age 36.38 years, with normal spirometry indices, acid-base status and arterial blood gases. The mean
smoking index was 11.28 smoking/years. All subjects were healthy, without any subjective health problems or disease in-
dicators. The aim was to define dead lung area (V/Q) as an early indicator of changes in smokers. Study results demon-
strated the mean shunt value in smokers of 8.25%, which showed positive correlation with smoking. The shunt size
yielded negative correlation with the forced expiratory volume in one second and midexpiratory flow in smokers. In con-
clusion, determination of lung shunt is a simple method that is sensitive enough in the diagnosis of initial lung lesion
due to cigarette smoking.
Key words: shunt, cigarette smoking
Introduction
Vein shunt is part of the high-impact volume that
passes from the right part of the heart through the lung
circulation and then moves into the arterial circulation
unoxygenated. In a healthy person, the physiological
part of the blood from bronchial veins and thebesian
veins and the usual virtual shunt with mild deviation in
the ventilation-perfusion ratio refers to physiological
shunt. Physiological shunt accounts for less than 7% of
the heart’s high-impact volume. The shunt is much gre-
ater in the presence of some heart diseases such as
right-left shunt in inborn heart anomalies such as inte-
ratrial or interventricular septal defects or in case of im-
balance of the ventilation-perfusion relations. While it is
relatively easy to prove the existence of shunt in heart
diseases, the size of shunt can only be demonstrated indi-
rectly in case of ventilation-perfusion impairment. The
size of shunt can be determined by mathematical calcula-
tion based on the shunt formula, taking into considera-
tion air humidity and oxygen solubility in the blood.
First, pure oxygen is inhaled for 30 minutes to wash off
nitrogen from the alveolus and to equalize the partial ox-
ygen pressure in the alveolus (PaO2) to partial oxygen
pressure (pO2) in the inhaled air. The partial oxygen
pressure in peripheral blood (PaO2) is measured. The
alveolus-arterial shunt is calculated using the Chanog
monogram, based on the parameters recorded1.
Smoking is one of the main risk factors causing poor
health condition and consequently death from diseases of
the cardiorespiratory tract2. The smokers’ quality of life
is greatly reduced as compared with nonsmokers, even in
the young age group free from other comorbidities3,4.
Smoking is one of the main risk factors in the develop-
ment of malignant diseases5. In addition, smoking is di-
rectly related to the development of chronic obstructive
lung disease, lung emphysema and chronic bronchitis6.
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On an average, smokers live fifteen years less than non-
smokers. Most smokers develop bronchiolitis of respira-
tory bronchioles (RB) associated with only scanty symp-
toms. However, in some smokers, alongside with inflam-
mation of respiratory bronchioles, pigmentophages clog
respiratory bronchioles and the associated acinus and
alveolus resulting in the development of bronchiolitis,
combined with interstitial disease (RB-ILD)7–9. In most
smokers with RB-ILD, the computerized tomography
(CT) finding is normal. Only when small nodes develop
in the lung parenchyma and subpleurally, the phenome-
non of »stained glass« and bronchiolar dilatation can be
seen on CT8,9. When it comes to the disease of the lung
parenchyma with the development of eosinophil nodes,
known as pulmonary histiocytosis of Langerhans cells or
eosinophil granulomas or histiocytosis, smokers tend
to develop the disease in 90% of cases. This disease
leads to total destruction of the lung parenchyma with
development of cysts. CT report depends on the stage
of the disease.
Spirometry parameters of the smokers’ lung function
remain normal until the late stage of the disease. Not un-
til the disease is fully developed obstructive and/or re-
strictive ventilation problems appear. The fall of the flow
value to the level of small bronchi in flow-volume curve
occurs earlier. The fall of the value of the midexpiratory
flow (FMF) and mild lowering of the transfer factors val-
ues indicates bronchiolitis and changes in the inter-
stitium of the lung parenchyma10.
Because of the low sensitivity of radiological tests11
and the fall of the values of spirometry parameters, tests
that are more sensitive should be used before advanced
lesions have occurred, i.e. tests that will detect earlier
the inflammation of respiratory bronchioles.
Subjects and Methods
The study included a sample consisting of 31 subjects,
20 (65%) men and 11 (35%) women, mean age 36.38
(standard deviation, SD 10.86) years and mean smoking
index 11.28 smoking/years (Table 1). On clinical exami-
nation, all study subjects were found to be healthy and
free from subjective complaints or any disease symp-
toms. Data on their smoking habit were collected and
smoking index was calculated from their history data.
Spirometry, i.e. the flow/volume curve, was performed on
a MasterLab device12 and the results were compared
with standard values according to Cotes13. Arterial blood
gas analysis was done on a Radiometer abl 1 device.
Shunt was calculated from the oxygen partial pressure
values before and after inhalation of 100% oxygen by use
of Chiang nomogram1. The basic statistical parameters
of the pulmonary ventilation function variables and cor-
relation coefficients between these variables were calcu-
lated and are reported.
Results
The mean (±SD) vital capacity (VC) (%) was 99.67%
(5249.82 l) (SD 11.36%), minimum 66.03% and maxi-
mum 118.78%; the mean forced expiratory volume in one
second (FEV1, %) was 106.25%, maximum 133.18%; and
the mean FMF (%) was 99.36% (SD 37.62%), minimum
18% and maximum 167% (Table 2).
The mean pH value was 7.37 (SD 0.02), minimum
value 7.32 and maximum 7.43; the mean pCO2 value was
4.99 (SD 0.42), minimum 9.82 and maximum 5.99; the
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TABLE 1
DESCRIPTIVE CHARACTERISTICS OF STUDY SUBJECTS AND
SMOKING INDEX
Variable X SD Range MIN MAX Count
Age (yrs) 36.38 10.86 40 19 59 31
Smoking index
(packs/year)
11.28 13.74 60 0 60 30
TABLE 2
DESCRIPTIVE CHARACTERISTICS OF THE LUNG VENTILATION
FUNCTION IN STUDY SUBJECTS
Variable X SD Range MIN MAX Count
VC (%) 99.67 11.36 53.00 66.00 119.00 29
VC (L) 5308.96 1234.76 4700 2100 6800 29
FEV1 (%) 106.25 16.09 82.00 51.00 130.00 29
FEV1 (L/sec) 4356.55 1107.92 4920 1180 6100 29
FMF % 99.36 37.62 149.00 18.00 167.00 23
FMF (L/sec) 0.04 0.02 0.08 0.04 0.08 23


























0 2 4 6 8 10 12 14
Fig. 1. Correlation between shunt and forced expiratory volume in one second.
mean pO2 value was 13.22 (SD 1.29), minimum 9.82 and
maximum 15.54; and the mean shunt value was 8.25 (SD
2.80), minimum 1.75 and maximum 13.50 (Table 3).
The coefficient of linear correlation between FEV1 (%)
and shunt was –0.385 and was statistically significant
(p0.05), yielding negative correlation between FEV1 (%)
and shunt; the correlation coefficient was statistically
significant at the level of 5% (Fig. 1).
The coefficient of linear correlation between FMF (%)
and shunt was –0.548 and was statistically significant
(p0.01), yielding negative correlation between FMF (%)
and shunt; the correlation coefficient was statistically
significant at the level of 1% (Fig. 2).
The coefficient of linear correlation between smoking
and shunt was 0.523 and was statistically significant
(p=0.000), yielding positive correlation between smoking
and shunt; the correlation coefficient was statistically
significant at the level of 1% (Fig. 3).
The coefficient of linear correlation between FMF (%)
and smoking was –0.409 and was statistically significant
(p0.05), yielding negative correlation between FMF (%)
and smoking; the correlation coefficient was statistically
significant at the level of 10% (Fig. 4).
Discussion
In their study carried out in 2003, Samard`i} et al.
found that one million people in Croatia, i.e. every third
inhabitant of Croatia, were smokers14, clearly pointing to
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Fig. 2. Correlation between shunt and forced midexpiratory flow.
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Fig. 3. Correlation between shunt and smoking.
TABLE 3
ARTERIAL BLOOD GAS ANALYSIS AND SHUNT IN STUDY
SUBJECTS
Variable X SD Range MIN MAX Count
pH 7.37 0.02 0.10 7.32 7.43 30
pCO2 4.99 0.42 1.60 4.39 5.99 30
pO2 13.22 1.29 5.72 9.82 15.54 30
Shunt 8.25 2.80 11.75 1.75 13.50 29
pH – acidity, pCO2 – carbon dioxide partial pressure, pO2 – oxy-
gen partial pressure
the severity of the problem. Their further study revealed
middle aged men to be heavy smokers and women light
smokers in Croatia15.
Smoking is an important risk factor in all cardio-
respiratory diseases2. Smoking is directly related to de-
velopment of diseases of the lung interstitium, combined
with bronchiolitis of respiratory bronchioles (RB-ILD,
desquamative pneumonitis), histiocytosis of Langerhans
cells and idiopathic lung fibrosis. The inflammation first
develops in the area of respiratory bronchioles, and in
this stage the disease is without clinical symptoms. In-
flammation with accumulation of inflamed cells devel-
ops, alongside with hypertrophy of the bronchiole wall
and closing of the lumen with mucus16. No changes can
be seen on standard radiological or CT findings. Spiro-
metry finding is also normal. However, symptoms de-
velop later, making the disease detectable too late due to
its gradual and insidious development.
All study subjects were smokers with smoking index
of 11.24 packs/year. They had no health problems or
symptoms. The mean shunt value was 8.25, showing a
statistically significant increase and linear correlation
between shunt and smoking. That means that the in-
flammation of the respiratory bronchiole wall causes ob-
struction distally in the associated acinus and alveolus,
and thus decreased ventilation. A part of the heart high-
-impact volume passing through that capillary bed is not
oxygenated because this part of the alveolus is not venti-
lated. The only way to prove this pathologic shunt is by
measuring the alveolus-arterial gradient (A/a). Using
this method we proved that the shunt was increased in
smokers that were free from any health complaints. That
means that the inflammation of respiratory bronchioles
was present, with consequential termination of ventila-
tion in that part of the lungs7,8. The only therapy to stop
further development of histopathologic lesions is giving
up smoking16. Although the results of spirometry were
within the limits of reference values, analysis of their
correlation with smoking showed negative correlation of
FEV1 and FMF with smoking. Because of the large span
of the normal values of this parameter, ±20%, the method
is not sensitive enough to prove any changes in this stage
of disease development17. In our subjects, peripheral
blood gas values were normal. Because of this and due to
the absence of symptoms in smokers, shunt measure-
ment appears to be the only diagnostic method at the
time when bronchiolitis is present alone, as it can indica-
te some lesions that will progress unless ceasing smoking.
If a smoker does not quit smoking, interstitial pneu-
monitis will develop in addition to bronchiolitis. This
usually occurs in smokers whose smoking index is over
30 packs/year. Alveolar macrophages with pigmented cy-
toplasm (pigmentophages) develop distally from respira-
tory bronchioles in corresponding acinus and alveolus.
Alveolar sepsis in the area around the bronchiole be-
comes thick because of fibrosis changes, but these usu-
ally do not transform into fibrosis interstitial changes.
Further progression, if one does not stop smoking, causes
irreversible destruction of the lungs with emphysema.
Accordingly, we believe that shunt is a simple diagnos-
tic method, important for early diagnosis of lung lesions
caused by smoking. It is especially important because at
the stage of respiratory bronchiolitis, there is no other
method available to objectify these lesions.
Conclusion
In our study sample, all spirometry parameters and
blood gas results were within the reference values. How-
ever, there was negative linear correlation of the forced
expiratory volume in one second (FEV1) and midexpi-
ratory flow (FMF) with smoking, while the mean shunt
value was 8.25, considerably exceeding the allowed limit
of 5. Shunt was found to correlate positively with smok-
ing and negatively with FEV1 and FMF.
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Fig. 4. Correlation between smoking and forced midexpiratory flow.
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[ANT U DIJAGNOSTICI PO^ETNIH O[TE]ENJA PLU]A KOD PU[A^A
S A @ E T A K
Pu{enje je bitan rizi~ni ~imbenik za sve bolesti di{nog sustava. Na`alost, simptomi se sporo razvijaju, tako da bole-
snici kasno po~nu osje}ati posljedice kroni~ne upale koja se razvija postupno i podmuklo. Upala najprije nastaje u pod-
ru~ju respiracijskih bronhiola. Tada je bolest asimptomatska. Analiza je provedena na uzorku od 31 pu{a~a prosje~ne
dobi 36,38 godina koji su imali uredne spirometrijske pokazatelje, acidobazni status i plinove arterijske krvi. Prosje~ni
indeks pu{enja je bio 11,28 pakovanja/godina. Svi ispitanici bili su zdravi, bez subjektivnih tegoba ili pokazatelja bolesti.
Cilj je bio odredili mrtvi prostor u plu}ima (V/Q) kao rani pokazatelj promjena kod pu{a~a. Dokazana je srednja vrijed-
nost {anta kod pu{a~a od 8,25% i njezina korelacija s pu{enjem. Veli~ina {anta bila je u negativnoj korelaciji s forsiranim
ekspiracijskim volumenom u prvoj sekundi i srednjim ekspiracijskim protokom kod pu{a~a. Zaklju~uje se da je odre-
|ivanje plu}nog {anta jednostavna metoda koja je dovoljno osjetljiva u dijagnostici po~etnih promjena u plu}ima koje
nastaju kao posljedica pu{enja.
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